Browse Topic
Research
-
May 13, 2022‘Friendly’ gut bacteria may eliminate pathogens by competing for energy resources
New research from scientists at UC Davis Health provides clues for how friendly bacteria in the gut — probiotics — may help eradicate bacterial pathogens like Salmonella by being able to compete with them for needed resources.
Read More -
May 11, 2022Discovery of cell protein that keeps Kaposi’s sarcoma herpesvirus dormant
A study led by UC Davis Cancer Center identified a binding protein in cancer cell’s nucleus, known as CHD4, as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body’s immune system. CHD4 is linked to cancer cell growth in many types of cancers.
Read More -
May 10, 2022Long-term national study of pregnant women finds increase in chemical exposure
A national 12-year study that enrolled a highly diverse group of pregnant women, including women in the Sacramento region, found rising exposure to chemicals from plastics and pesticides that may be harmful to fetal development.
Read More
-
April 27, 2022Researchers receive $1.2 million NIH grant to study synthetic data use in health care
Three researchers from UC Davis have been awarded a $1.2 million grant from the National Institutes of Health to generate high-quality synthetic data using artificial intelligence and machine learning. The research may help physicians predict, diagnose and treat diseases.
Read More -
April 26, 2022Can you guess how many lab tests were performed at UC Davis Health last year?
Can you guess how many lab tests were performed at UC Davis Health last year? Or which five are the most common? Here is a snapshot of the critical contributions of our dedicated lab professionals as we celebrate Medical Laboratory Professionals Week, April 24-30, 2022.
Read More -
April 19, 2022UC Davis Health received 2022 Top Ten Clinical Research Achievement Award
In recognition of her remarkable work studying opioid dose tapering, Alicia Agnoli was honored with a 2022 Top Ten Clinical Research Achievement Award. The award recognizes groundbreaking achievements in clinical research from across the U.S.
Read More -
April 15, 2022UC Davis telehealth leader selected as Fulbright U.S. Scholar
James Marcin, director of the UC Davis Center for Health and Technology, vice chair for pediatric clinical research and professor of pediatrics, has been selected as a Fulbright U.S. Scholar for 2022-2023. The program offers more than 400 awards in more than 130 countries.
Read More -
April 07, 2022Study shows need to increase screening for unhealthy alcohol use during primary care visits
A new study shows screening for unhealthy alcohol consumption using a validated questionnaire is rarely performed during primary care visits. Researchers found that alcohol use disorder was documented during less than 3% of office visits over a three-year period.
Read More -
April 06, 2022It’s not just transportation, it’s health justice for patients
In a Q&A with Na’amah Razon, assistant professor of family and community medicine at UC Davis Health, we learn about the importance of transportation for patients and how that shapes their access to health care.
Read More -
April 05, 2022School of Medicine students gain experience working on new study
School of Medicine students have gained experience conducting research on a study looking at spinal cord function. Researchers and medical students are working with patients diagnosed with degenerative cervical myelopathy to establish better tools for diagnosis.
Read More -
April 04, 2022Diabetic ulcers affect the skin, cognition and mental health
Learn how to prevent and treat diabetic ulcers from UC Davis Health Dermatologist Roslyn Isseroff. Discover how chronic wounds affect the skin, mind and memory through the skin-brain connection.
Read More -
April 04, 2022Autism characteristics can change significantly from ages 3 to 11
In two studies, UC Davis MIND Institute researchers have found that the character of a child’s autism traits can change significantly over time. In this Q&A, they discuss what the changes are and what may be driving them.
Read More -
April 01, 2022New human reference genome opens unexplored regions
A new complete sequence of the human genome has been published by an international consortium of scientists. The research team includes Megan Dennis of the UC Davis MIND Institute and other UC Davis investigators.
Read More
-
March 31, 2022New insights into FXTAS could inform future research and clinical trials
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive genetic condition that causes movement challenges and cognitive decline. UC Davis MIND Institute researchers have shown, for the first time, how FXTAS can manifest in its earliest stages.
Read More -
March 30, 2022Barton Health and UC Davis Health expand partnership to improve trauma care for children
Barton Memorial Hospital is participating in an ongoing clinical trial by UC Davis Health, aimed at improving trauma care for children in the region. The study was designed for pediatric trauma patients who require a transfer to a higher level of care.
Read More -
March 29, 2022$4 million research program seeks therapy for rare genetic condition ADNP syndrome
The UC Davis MIND Institute is launching a $4 million research program aimed at finding transformative therapies for ADNP syndrome, a rare genetic condition. A group of interdisciplinary researchers will evaluate multiple gene therapies for possible use.
Read More -
March 25, 2022Half of all women experience false positive mammograms after 10 years of annual screening
Half of all women experience a false positive mammogram after 10 years of annual breast cancer screening with 3D mammography, a UC Davis-led study estimates. This risk was lower for women who had mammograms every other year. 3D screening showed slightly lower false positive results than standard mammography.
Read More -
March 24, 2022Harnessing the power of RORγ in control of cancer and cholesterol metabolism
In a Q&A, Hongwu Chen, the director of the Cancer Metabolism Initiative of the UC Davis Comprehensive Cancer Center, discussed how a special receptor protein (RORγ) impacts cancer growth and cholesterol synthesis. RORγ may be an effective target to treat cancer.
Read More -
March 24, 2022Could CAR T cells offer hope for an HIV cure?
Researchers have launched a study to identify a potential cure for HIV. Using a new immunotherapy approach, researchers will use a patient's white blood cells and modify them so they can identify and target HIV cells to control the virus.
Read More -
March 21, 2022New method increases preventive health screenings for older patients
A new study aimed to increase adherence to the recommended health screening and vaccine recommendations for patients ages 50 and older during patient visits. It was led by physicians, surgeons and public health specialists and utilized an electronic population health tool.
Read More